ANEBULO PHARMACEUTICALS INC (ANEB)
OTCHealth CareBiotechnologySnapshot 2026-09-04
$0.36-8.05%
Close 2026-09-04 · 1-day change
OTCHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ANEB
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of — · Company calendar date is not available
ANEB — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar…
Dated 2026-02-06
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 5, 2026, the Board of Directors (the “Board”) of Anebulo Pharmaceuticals, Inc., a Delaware corporation (“Anebulo” or the “Company”) approved the voluntary delisting of the Company’s common stock, par value $0.001 per share (“Common Stock”), from The Nasdaq Capital Market (“Nasdaq”) and the subsequent voluntary deregistration of the Common Stock with the Securities and Exchange Comm…
Why it matters: What management says about spending shows how they feel about future growth.
Watch forManagement shares plans to invest in growth projects or research.
Also watch forManagement shows they may cut spending or focus on saving money.
Why it matters: If health care revenue growth speeds up, it could benefit ANEB's market position.
Supportive ifHealth care revenue growth accelerates back toward 9% or higher.
Worry ifHealth care revenue growth continues to decelerate below 9%.
Why it matters: The earnings date will show how the company is doing. It will also give hints about future plans.
Watch forANEB will share an earnings date with good news about revenue or profit.
Also watch forANEB will share an earnings date with bad news about revenue or profit.
Why it matters: The FOMC decision can impact market conditions and investor sentiment. This may affect ANEB's stock.
Watch forFOMC raises interest rates or signals a tightening stance.
Also watch forFOMC keeps interest rates steady or signals a loosening stance.
Why it matters: If revenue growth picks up, it may signal a positive shift in the company's performance.
Supportive ifANEB's revenue growth turns positive and exceeds 9% year over year.
Worry ifRevenue growth remains below 9% year over year or declines.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$318 on $10,000 · ±3.2% | How much price usually moves either way. |
| Bad day | $1,332 loss on $10,000 · 13.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,999 loss on $10,000 · 100.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.